To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for California's 6th congressional district. Democrat.
Last Updated: Sep 30, 2020
Length: 8 pages
What legislators are saying
H.R. 4764 is a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 4764. This is the one from the 116th Congress.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2020). H.R. 4764 — 116th Congress: TRANSPLANT Act of 2020. Retrieved from https://www.govtrack.us/congress/bills/116/hr4764
“H.R. 4764 — 116th Congress: TRANSPLANT Act of 2020.” www.GovTrack.us. 2019. October 22, 2020 <https://www.govtrack.us/congress/bills/116/hr4764>
TRANSPLANT Act of 2020, H.R. 4764, 116th Cong. (2019).
|title=H.R. 4764 (116th)
|accessdate=October 22, 2020
|author=116th Congress (2019)
|date=October 18, 2019
|quote=TRANSPLANT Act of 2020
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.